49.37
price down icon5.69%   -2.98
after-market Handel nachbörslich: 49.99 0.62 +1.26%
loading
Schlusskurs vom Vortag:
$52.35
Offen:
$49.91
24-Stunden-Volumen:
4.67M
Relative Volume:
1.70
Marktkapitalisierung:
$60.61B
Einnahmen:
$48.62B
Nettoeinkommen (Verlust:
$6.80B
KGV:
17.61
EPS:
2.8038
Netto-Cashflow:
$7.62B
1W Leistung:
-5.02%
1M Leistung:
-8.10%
6M Leistung:
+1.81%
1J Leistung:
+3.22%
1-Tages-Spanne:
Value
$48.59
$49.92
1-Wochen-Bereich:
Value
$48.59
$53.03
52-Wochen-Spanne:
Value
$45.80
$60.12

Sanofi Adr Stock (SNY) Company Profile

Name
Firmenname
Sanofi Adr
Name
Telefon
-
Name
Adresse
-
Name
Mitarbeiter
82,878
Name
Twitter
@sanofi
Name
Nächster Verdiensttermin
2024-10-25
Name
Neueste SEC-Einreichungen
Name
SNY's Discussions on Twitter

Vergleichen Sie SNY mit anderen Aktien

Aktien Preis Marktkapitalisierung Umsatz Nettogewinn Free Cashflow ENV
Drug Manufacturers - General icon
SNY
Sanofi Adr
49.37 126.50B 48.62B 6.80B 7.62B 2.8038
Drug Manufacturers - General icon
LLY
Lilly Eli Co
737.67 640.72B 49.00B 11.11B -1.27B 12.29
Drug Manufacturers - General icon
JNJ
Johnson Johnson
155.21 367.98B 89.33B 21.81B 18.57B 8.99
Drug Manufacturers - General icon
ABBV
Abbvie Inc
186.11 323.71B 57.37B 4.20B 15.39B 2.35
Drug Manufacturers - General icon
NVS
Novartis Ag Adr
115.76 222.69B 53.22B 12.86B 14.85B 6.39
Drug Manufacturers - General icon
NVO
Novo Nordisk Adr
71.50 299.26B 43.59B 15.04B 10.74B 3.3766

Sanofi Adr Stock (SNY) Upgrades & Downgrades

Datum Aktion Analytiker Ratingänderung
2025-04-15 Eingeleitet Exane BNP Paribas Outperform
2025-03-21 Eingeleitet Goldman Neutral
2025-01-30 Hochstufung Deutsche Bank Sell → Hold
2024-07-26 Bestätigt Argus Buy
2024-01-23 Eingeleitet Morgan Stanley Equal-Weight
2024-01-16 Fortgesetzt UBS Buy
2023-12-05 Herabstufung JP Morgan Overweight → Neutral
2023-10-30 Herabstufung Stifel Buy → Hold
2023-09-06 Hochstufung Berenberg Hold → Buy
2023-07-14 Eingeleitet HSBC Securities Buy
2023-04-28 Herabstufung Deutsche Bank Hold → Sell
2023-03-27 Hochstufung Barclays Equal Weight → Overweight
2022-12-13 Fortgesetzt Morgan Stanley Overweight
2022-08-12 Hochstufung Deutsche Bank Sell → Hold
2022-08-09 Herabstufung UBS Buy → Neutral
2022-05-23 Eingeleitet SVB Leerink Outperform
2021-09-27 Hochstufung SVB Leerink Mkt Perform → Outperform
2021-01-15 Eingeleitet Deutsche Bank Sell
2020-09-29 Eingeleitet Berenberg Hold
2020-03-17 Hochstufung Barclays Underweight → Equal Weight
2020-03-11 Hochstufung Goldman Neutral → Buy
2020-02-11 Eingeleitet SVB Leerink Mkt Perform
2020-01-06 Hochstufung JP Morgan Neutral → Overweight
2019-09-23 Hochstufung Guggenheim Neutral → Buy
2019-09-20 Hochstufung Morgan Stanley Equal-Weight → Overweight
2019-09-03 Eingeleitet Bernstein Outperform
2019-08-14 Hochstufung UBS Neutral → Buy
2018-12-11 Hochstufung Jefferies Hold → Buy
2018-11-01 Hochstufung Barclays Underweight → Equal Weight
2018-10-09 Eingeleitet Guggenheim Neutral
2018-09-10 Hochstufung BofA/Merrill Neutral → Buy
2018-08-10 Hochstufung Citigroup Neutral → Buy
2018-03-23 Hochstufung Liberum Hold → Buy
2018-01-23 Herabstufung Barclays Equal Weight → Underweight
2017-12-06 Herabstufung BofA/Merrill Buy → Neutral
2017-12-01 Herabstufung Morgan Stanley Overweight → Underweight
2017-11-15 Hochstufung Barclays Underweight → Equal Weight
2017-08-30 Hochstufung HSBC Securities Reduce → Hold
Alle ansehen

Sanofi Adr Aktie (SNY) Neueste Nachrichten

pulisher
May 30, 2025

Regeneron and Sanofi: Disappointing Top-Line Results for Itepekimab From Two Phase 3 Trials - Morningstar

May 30, 2025
pulisher
May 30, 2025

Regeneron Pharmaceuticals Crashes 19% On A Surprise Sanofi-Tied Failure - Investor's Business Daily

May 30, 2025
pulisher
May 30, 2025

Market movers: Canopy Growth, Zscaler, Regeneron... - Proactive financial news

May 30, 2025
pulisher
May 30, 2025

Regeneron, Sanofi Stock Falls After Uneven Smoker's Lung Drug Data - Benzinga

May 30, 2025
pulisher
May 30, 2025

Regeneron shares plunge after mixed COPD drug trial results - Proactive financial news

May 30, 2025
pulisher
May 29, 2025

Penicillin Market Research Report 2025 - GlobeNewswire Inc.

May 29, 2025
pulisher
May 26, 2025

Prurigo Nodularis Market - GlobeNewswire Inc.

May 26, 2025
pulisher
May 23, 2025

8MM Bronchiectasis Market Opportunity Assessment and Forecasts, 2033 - GlobeNewswire Inc.

May 23, 2025
pulisher
May 22, 2025

Dollar Stock Biotech Triples On $470 Million Sanofi Takeover - Investor's Business Daily

May 22, 2025
pulisher
May 19, 2025

Weekly Stock Grader Analysis: Upgrades & Downgrades on Top Blue-Chip Stocks - InvestorPlace

May 19, 2025
pulisher
May 08, 2025

Metric Deep Dive: Understanding Sanofi ADR (SNY) Through its Ratios - DWinneX

May 08, 2025
pulisher
May 02, 2025

iRhythm Technologies Inc (IRTC) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

WLK’s Stock Market Puzzle: Piecing Together 2023’s Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

BIDU’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

A Tale of Resilience: Sanofi ADR Amid Stock Market Turbulence - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Company’s Banking Stock: Dissecting a 40.08% Quarterly Revenue Decline Amid Growth - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Trip.com Group Ltd ADR (TCOM) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CYTK’s 2023 Market Dance: Down -21.41% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CIG’s Market Whiplash: 8.19% YTD Rise, 9.30% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Can Navitas Semiconductor Corp Bounce Back? 52-Week Performance and Analyst Predictions - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LX’s 2023 Market Dance: Up 43.28% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Terex Corp (TEX) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Behind Cytosorbents Corp’s 52-Week Range: Uncovering Opportunities for Investors - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Procore Technologies Inc (PCOR) Stock: A 52-Week Tale of Drops and Gains - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Navigating TREE Stock: LendingTree Inc Journey - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Companhia Siderurgica Nacional ADR (SID) Stock: From Low to High in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Future of EVgo Inc: Analyzing EVGO - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Analyzing the Impact of Earnings Reports on Sunstone Hotel Investors Inc Inc. (SHO) Price Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

NVS’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Unilever plc ADR: Rising -3.90% from 52-Week Low, Can the Stock Stay Afloat? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

TTWO’s Stock Market Pendulum: Swinging Between Gains and Losses - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Futu Holdings Ltd ADR (FUTU) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Stryker Corp (SYK) Stock: Navigating a Year of Volatility - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Viking Holdings Ltd’s Banking’s 100-Day Moving Average at 44.43: Will the Stock Break Through? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CTRE’s Market Whiplash: 5.78% YTD Rise, 0.22% Rise in 30 Days - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Sandisk Corp (SNDK) Stock: Navigating Market Highs and Lows in 52 Weeks - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

LSCC: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Canadian National Railway Co: Navigating Market Fluctuations with a 62.62B Market Cap - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

DUOL’s 2023 Market Dance: Up 43.43% – Time to Invest? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CF Industries Holdings Inc (CF) Stock: A Year of Stock Market Ups and Downs - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

PLRZ Stock: Exploring Polyrizon Ltd’s Growth - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Sumitomo Mitsui Financial Group Inc ADR (SMFG) Stock: A Year of Market Movement, Down and Up - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Vipshop Holdings Ltd ADR Inc. (VIPS) Price Performance: The Role of Supply and Demand - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Uncovering the Potential of American Homes 4 Rent (AMH) Stock - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Significance of Moving Averages in Live Nation Entertainment Inc Inc. (LYV) Price Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

APG’s Stochastic Averages Dip: Analyzing APi Group Corporation’s Stock Performance - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

CNMD’s 52-Week Rollercoaster: From $46.00 to $78.58 – What’s Next for Investors? - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

AngloGold Ashanti Plc (AU) Stock: 52-Week Performance Insights and Trading Volume - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

UDMY: Riding the Market Waves of Growth and Decline in 2023 - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

The Future of Tyson Foods, Inc: Analyzing TSN - investchronicle.com

May 02, 2025
pulisher
May 02, 2025

Hologic, Inc’s Bumpy Road: Analyzing the 52-Week Range and Future Prospects - investchronicle.com

May 02, 2025

Finanzdaten der Sanofi Adr-Aktie (SNY)

Umsatz

loading

Nettogewinn

loading

Free Cashflow

loading

ENV

loading
drug_manufacturers_general PFE
$23.49
price up icon 0.17%
$110.08
price down icon 0.93%
$288.18
price up icon 1.64%
drug_manufacturers_general GSK
$41.03
price up icon 2.58%
drug_manufacturers_general MRK
$76.84
price up icon 0.58%
drug_manufacturers_general NVO
$71.50
price up icon 2.94%
Kapitalisierung:     |  Volumen (24h):